{
  "paper_id": "3150eb5e7cad373df8bc4cb9cd052204ec19a5b6",
  "metadata": {
    "title": "Circulating mannan-binding lectin, M-, L-, H-ficolin, and collectin-liver-1 levels in patients with acute liver failure",
    "coda_data_split": "train",
    "coda_paper_id": 5111,
    "coda_has_expert_labels": false,
    "subset": "custom_license"
  },
  "abstract": [
    {
      "original_text": "Background-The complement system is activated in liver diseases including acute liver failure (ALF); however, the role of the lectin pathway of complement has scarcely been investigated in ALF. The pathway is initiated by soluble pattern recognition molecules: mannan-binding lectin (MBL), M-, L-and H-ficolin and collectin-liver-1 (CL-L1), which are predominantly synthesised in the liver.",
      "sentences": [
        [
          {
            "segment_text": "Background-The complement system is activated in liver diseases including acute liver failure ( ALF ) ; however ,",
            "crowd_label": "background"
          },
          {
            "segment_text": "the role of the lectin pathway of complement has scarcely been investigated in ALF .",
            "crowd_label": "background"
          }
        ],
        [
          {
            "segment_text": "The pathway is initiated by soluble pattern recognition molecules : mannan-binding lectin ( MBL ) ,",
            "crowd_label": "background"
          },
          {
            "segment_text": "M - , L-and H-ficolin and collectin-liver-1 ( CL-L1 ) ,",
            "crowd_label": "background"
          },
          {
            "segment_text": "which are predominantly synthesised in the liver .",
            "crowd_label": "background"
          }
        ]
      ]
    },
    {
      "original_text": "Methods-Serum samples from 75 patients enrolled by the U.S. ALF Study Group were collected on days 1 and 3. We included 75 healthy blood donors and 20 cirrhosis patients as controls. Analyses were performed using sandwich-type immunoassays (ELISA, TRIFMA).",
      "sentences": [
        [
          {
            "segment_text": "Methods-Serum samples from 75 patients enrolled by the U.S. ALF Study Group were collected on days 1 and 3 .",
            "crowd_label": "method"
          }
        ],
        [
          {
            "segment_text": "We included 75 healthy blood donors and 20 cirrhosis patients as controls .",
            "crowd_label": "method"
          }
        ],
        [
          {
            "segment_text": "Analyses were performed using sandwich-type immunoassays ( ELISA , TRIFMA ) .",
            "crowd_label": "method"
          }
        ]
      ]
    },
    {
      "original_text": "Results-At day 1, the MBL level in ALF patients was 40% lower compared with healthy controls ((median(interquartile range) 0.72 μg/ml(0.91) vs. 1.15(1.92)(p\u003d0.02)), and increased significantly by day 3 (0.83 μg/ml(0.94)(p\u003d0.01)). The M-ficolin level was 60% lower (0.54 μg/ ml(0.50) vs. 1.48(1.01)(p\u003c0.0001)). The CL-L1 level at day 1 was slightly higher compared with healthy controls (3.20 μg/ml(2.37) vs. 2.64(0.72)(p\u003d0.11)); this was significant at day 3 (3.35(1.84)(p\u003d0.006)). H-and L-ficolin levels were similar to healthy controls. Spontaneous ALF survivors had higher levels of MBL at day 1 (0.96 μg/ml(1.15) vs. 0.60(0.60)(p\u003d0.02)) and lower levels of L-ficolin by day 3 compared with patients who died or were transplanted (1.61 μg/ ml(1.19) vs. 2.17(2.19)(p\u003d0.02)).",
      "sentences": [
        [
          {
            "segment_text": "Results-At day 1 , the MBL level in ALF patients was 40 % lower compared with healthy controls ( ( median ( interquartile range ) 0.72 μg/ml ( 0.91 ) vs. 1.15 ( 1.92 ) ( p \u003d 0.02 ) ) ,",
            "crowd_label": "finding"
          },
          {
            "segment_text": "and increased significantly by day 3 ( 0.83 μg/ml ( 0.94 ) ( p \u003d 0.01 ) ) .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "The M-ficolin level was 60 % lower ( 0.54 μg / ml ( 0.50 ) vs. 1.48 ( 1.01 ) ( p \u003c 0.0001 ) ) .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "The CL-L1 level at day 1 was slightly higher compared with healthy controls ( 3.20 μg/ml ( 2.37 ) vs. 2.64 ( 0.72 ) ( p \u003d 0.11 ) ) ; this was significant at day 3 ( 3.35 ( 1.84 ) ( p \u003d 0.006 ) ) .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "H-and L-ficolin levels were similar to healthy controls .",
            "crowd_label": "finding"
          }
        ],
        [
          {
            "segment_text": "Spontaneous ALF survivors had higher levels of MBL at day 1 ( 0.96 μg/ml ( 1.15 ) vs. 0.60 ( 0.60 ) ( p \u003d 0.02 ) ) and lower levels of L-ficolin by day 3 compared with patients who died or were transplanted ( 1.61 μg / ml ( 1.19 ) vs. 2.17 ( 2.19 ) ( p \u003d 0.02 ) ) .",
            "crowd_label": "finding"
          }
        ]
      ]
    }
  ],
  "abstract_stats": {
    "paragraph_num": "3",
    "sentence_num": "10",
    "segment_num": "14",
    "token_num": "323"
  }
}